Ping An Biomedical Co., Ltd.

PASWNASDAQIndustrials● Active

$0.18

+$0.02(+12.05%)

Market Cap$3333489

P/E Ratio—

52W High$5.4

52W Low$0.121

Avg Volume272K

Open$0.16

Beta2.74

Free Cash Flow Financials Revenue

Ping An Biomedical Co., Ltd. (PASW) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

PASW · free cash flow · updated Jun 8, 2026

Core FCF metrics

PASW · FCF · TTM · margin & CAGR

Free cash flow was $14.6M for FY2024 (fiscal year ending 2024-09-30), up 340.5% year-over-year The FCF margin was 16.7%.

FY2024 Free Cash Flow$14.6M▲ +340.5% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

FCF Margin16.7%$14.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

PASW · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$14.6M(0M)$14.6M▲ +340.5%16.7%

FY2023−$6.1M(0M)−$6.1M▼ 128.9%-7.4%

FY2022$21.1M(0M)$21.1M▲ +167.1%18.4%

FY2021−$31.4M(0M)−$31.4M—-31.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

PASW · P/FCF · FCF yield · FCF per share

Ping An Biomedical Co., Ltd. (PASW) trades at a FCF yield of 64.71% and a price-to-free-cash-flow ratio of N/A. FCF per share stands at N/A, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

64.71%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

x2.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-09-30

Cash flow statement summary

PASW · cash flow statement · operating / investing / financing

For FY2024, Ping An Biomedical Co., Ltd. generated $14.6M in operating cash flow and spent 0M in capital expenditures, yielding $14.6M in free cash flow.

Operating Activities

+$14.6M

Cash from core business operations

2024-09-30

Investing Activities

+$15.0M

CapEx, acquisitions & investments

2024-09-30

Financing Activities

−$30.1M

Buybacks, dividends & debt

2024-09-30

FCF FormulaOperating CF ($14.6M) − |CapEx| (0M) = FCF ($14.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Industrials)

PASW vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Ping An Biomedical Co., Ltd.YOU

PASW

$14.6M+340.5%16.7%

Space Exploration Technologies Corp.

SPCX

−$13.95B-159.0%-74.7%

Loss

Industrials · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Ping An Biomedical Co., Ltd. (PASW) reported free cash flow of $14.6M for FY2024 (fiscal year ending 2024-09-30), up 340.5% year-over-year. The FCF margin was 16.7%.

Based on available data, Ping An Biomedical Co., Ltd. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $21.1M in FY2022.

Ping An Biomedical Co., Ltd.'s FCF yield is 64.71% and price-to-FCF ratio is N/A for FY2024, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

PASW free cash flow · 8 questions

Ping An Biomedical Co., Ltd. free cash flow was $14.6M for FY2024, up 340.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at —.

PASW free cash flowPASW FCFPASW FCF 2024PASW free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Ping An Biomedical Co., Ltd. · Ping An Biomedical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026